Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma.
Tuberculosis (TB) granulomas are organized collections of immune cells comprised of macrophages, lymphocytes and other cells that form in the lung as a result of immune response to Mycobacterium tuberculosis (Mtb) infection. Formation and maintenance of granulomas are essential for control of Mtb infection and are regulated in part by a pro-inflammatory cytokine, tumor necrosis factor-alpha (TNF). To characterize mechanisms that control TNF availability within a TB granuloma, we developed a multi-scale two compartment partial differential equation model that describes a granuloma as a collection of immune cells forming concentric layers and includes TNF/TNF receptor binding and trafficking processes. We used the results of sensitivity analysis as a tool to identify experiments to measure critical model parameters in an artificial experimental model of a TB granuloma induced in the lungs of mice following injection of mycobacterial antigen-coated beads. Using our model, we then demonstrated that the organization of immune cells within a TB granuloma as well as TNF/TNF receptor binding and intracellular trafficking are two important factors that control TNF availability and may spatially coordinate TNF-induced immunological functions within a granuloma. Further, we showed that the neutralization power of TNF-neutralizing drugs depends on their TNF binding characteristics, including TNF binding kinetics, ability to bind to membrane-bound TNF and TNF binding stoichiometry. To further elucidate the role of TNF in the process of granuloma development, our modeling and experimental findings on TNF-associated molecular scale aspects of the granuloma can be incorporated into larger scale models describing the immune response to TB infection. Ultimately, these modeling and experimental results can help identify new strategies for TB disease control/therapy.
Fallahi-Sichani
Mohammad
M
Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA.
Schaller
Matthew A
MA
Kirschner
Denise E
DE
Kunkel
Steven L
SL
Linderman
Jennifer J
JJ
D000465:Algorithms; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D003198:Computer Simulation; D003713:Dendritic Cells / Q000276:immunology; D006099:Granuloma / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008808:Mice, Inbred CBA; D008954:Models, Biological; D009169:Mycobacterium tuberculosis; D011485:Protein Binding; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D014373:Tuberculin / Q000378:metabolism; D014376:Tuberculosis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism*
D018124:Receptors, Tumor Necrosis Factor; D014373:Tuberculin; D014409:Tumor Necrosis Factor-alpha
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4628-33
11274375
J Biol Chem. 1990 Sep 5;265(25):15183-8
2168404
Cancer Res. 1992 Oct 15;52(20):5838-44
1394212
Infect Immun. 1997 Jan;65(1):298-304
8975927
Biotechnol Bioeng. 1999 Mar 5;62(5):562-75
10099565
Infect Immun. 2006 Jul;74(7):3790-803
16790751
Microbes Infect. 2007 Apr;9(5):623-8
17409008
Nat Immunol. 2009 Aug;10(8):918-26
19597496
J Immunol. 1994 Apr 1;152(7):3550-8
8144934
Infect Immun. 2008 Mar;76(3):916-26
18212087
J Pathol. 2006 Jan;208(2):261-9
16362982
J Exp Med. 1992 Feb 1;175(2):323-9
1310100
PLoS One. 2009 Jun 16;4(6):e5928
19529765
J Biol Chem. 1992 Oct 15;267(29):21172-8
1328224
J Immunol. 1997 Nov 1;159(9):4524-31
9379053
J Investig Dermatol Symp Proc. 2007 May;12(1):52-6
17502872
Cancer Res. 1984 Jan;44(1):238-44
6197161
Nature. 1994 Jul 21;370(6486):218-20
8028669
Ann Rheum Dis. 2001 Nov;60 Suppl 3:iii25-32
11890648
Cell Death Differ. 2003 Jan;10(1):45-65
12655295
Immunity. 1995 Jun;2(6):561-72
7540941
Cell Microbiol. 2006 Feb;8(2):218-32
16441433
Am J Pathol. 1994 Nov;145(5):1105-13
7977642
BMC Bioinformatics. 2007 Oct 09;8:376
17925009
Nat Rev Microbiol. 2007 Jan;5(1):39-47
17160001
Immunity. 2008 Aug 15;29(2):283-94
18691913
J Biol Chem. 1987 May 25;262(15):6951-4
3034874
Clin Immunol. 2009 May;131(2):308-16
19188093
J Immunol. 1997 Oct 1;159(7):3565-73
9317156
Pharmacol Ther. 2008 Feb;117(2):244-79
18155297
Infect Immun. 2005 Jun;73(6):3668-76
15908396
Cytokine Growth Factor Rev. 2003 Dec;14(6):467-77
14563349
J Cell Sci. 2002 Jul 1;115(Pt 13):2757-70
12077366
PLoS One. 2009 Aug 11;4(8):e6604
19668374
Nat Med. 2003 Aug;9(8):1039-46
12872166
PLoS Comput Biol. 2007 Jan 12;3(1):e6
17222056
Immunol Rev. 2007 Apr;216:93-118
17367337
Biochem J. 1992 Jun 15;284 ( Pt 3):905-10
1622406
PLoS Comput Biol. 2007 Oct;3(10):1909-24
17953477
Immunol Cell Biol. 1996 Oct;74(5):465-72
8912010
Ann Biomed Eng. 2008 Mar;36(3):486-512
18183487
Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii37-42
14532147
J Immunol. 2001 Aug 1;167(3):1230-7
11466338
Trends Cell Biol. 1995 Oct;5(10):392-9
14732063
Cell Physiol Biochem. 2007;20(5):559-68
17762182
J Investig Dermatol Symp Proc. 2007 May;12(1):22-5
17502865
J Theor Biol. 2008 Sep 7;254(1):178-96
18572196
Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):34-8
15852254
Biotechnol Bioeng. 2007 Aug 1;97(5):1216-29
17171720
J Cell Biochem. 1994 Apr;54(4):453-64
8014194
Immunol Lett. 2004 Mar 29;92(1-2):135-42
15081537
Rheumatology (Oxford). 2005 Mar;44(3):323-31
15585509
J Immunol. 1987 Nov 1;139(9):2989-92
2822800
J Immunol. 1998 Jan 15;160(2):943-52
9551933
Pflugers Arch. 2000;439(3 Suppl):R113-5
10653161
Am J Pathol. 2004 Mar;164(3):1021-30
14982855
Immunol Res. 2006;36(1-3):157-65
17337776
J Immunol. 2009 Mar 15;182(6):3706-17
19265149
N Engl J Med. 2001 Oct 11;345(15):1098-104
11596589
Infect Immun. 2008 Jul;76(7):3221-32
18443099
Arthritis Rheum. 2010 Feb;62(2):340-50
20112395
J Biol Chem. 1989 Aug 15;264(23):13623-31
2547769
J Mol Biol. 2007 Dec 14;374(5):1374-88
17996896
J Pharmacol Exp Ther. 2002 May;301(2):418-26
11961039
Biophys J. 1995 Sep;69(3):825-39
8519983
Am J Pathol. 2005 Apr;166(4):1109-20
15793291
Immunity. 2008 Feb;28(2):271-84
18261937
J Infect Dis. 2007 Jun 1;195(11):1643-50
17471434
Nephrol Dial Transplant. 2001 Jul;16(7):1430-5
11427636
J Exp Med. 1995 Mar 1;181(3):1205-10
7869036
FASEB J. 1989 Dec;3(14):2633-40
2556313
J Biol Chem. 2006 Feb 3;281(5):2945-50
16321974
Infect Immun. 2000 Jul;68(7):4264-73
10858244
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):570-5
9435233
Proc Natl Acad Sci U S A. 1985 Nov;82(22):7626-30
2999773
J Pathol. 2000 Feb;190(2):211-20
10657021
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4530-5
15767567
Immunity. 2008 Feb;28(2):146-8
18275827
J Biol Chem. 2005 Feb 18;280(7):5994-6004
15572357
Nat Clin Pract Rheumatol. 2006 Nov;2(11):602-10
17075599
Infect Immun. 2003 Feb;71(2):864-71
12540568
Tuberculosis (Edinb). 2004;84(1-2):93-101
14670350
J Immunol. 2004 Jun 1;172(11):6846-57
15153503
Am J Pathol. 2001 Apr;158(4):1503-15
11290568
J Immunol. 1995 Jun 1;154(11):5969-76
7751640
EMBO Mol Med. 2009 Apr;1(1):19-29
20049700
J Pharmacol Exp Ther. 1994 Apr;269(1):367-73
8169842
J Pharm Sci. 2004 Nov;93(11):2645-68
15389672
Tuberculosis (Edinb). 2002;82(2-3):55-61
12356455
J Pathol. 2004 Oct;204(2):217-28
15376257